Review article: immune suppression and colorectal cancer
作者： C. EVANS , A. G. DALGLEISH , D. KUMAR
DOI: 10.1111/J.1365-2036.2006.03075.X
关键词: Immune system 、 Immune surveillance 、 Review article 、 Immunology 、 Immunosuppression 、 Rectal disease 、 Colonic disease 、 Colorectal cancer 、 Medicine
摘要: SUMMARY Background Advances in immunology and molecular biology have shown that colorectal cancer is potentially immunogenic host immune responses influence survival. However, surveillance activation frequently ineffective preventing and/or controlling tumour growth. Aim To discuss potential ways which induces suppression, its effect upon prognosis avenues for therapeutic development. Method
researchgate.net 
sci-hub.se 参考文章(215)
JOE O'CONNELL, MICHAEL W. BENNETT, KENNETH NALLY, AILEEN HOUSTON, GERALD C. O'SULLIVAN, FERGUS SHANAHAN, Altered Mechanisms of Apoptosis in Colon Cancer: Fas Resistance and Counterattack in the Tumor‐Immune Conflict Annals of the New York Academy of Sciences. ,vol. 910, pp. 178- 195 ,(2006) , 10.1111/J.1749-6632.2000.TB06708.X
Michael A. Morse, Timothy M. Clay, Amy C. Hobeika, Takuya Osada, Shubi Khan, Stephen Chui, Donna Niedzwiecki, Dennis Panicali, Jeffrey Schlom, H. Kim Lyerly, Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory Molecules Clinical Cancer Research. ,vol. 11, pp. 3017- 3024 ,(2005) , 10.1158/1078-0432.CCR-04-2172
Nathalie Favre-Felix, Annie Fromentin, Arlette Hammann, Eric Solary, François Martin, Bernard Bonnotte, Cutting edge : The tumor counterattack hypothesis revisited : Colon cancer cells do not induce T-cell apoptosis via the Fas (CD95, APO-1) pathway Journal of Immunology. ,vol. 164, pp. 5023- 5027 ,(2000) , 10.4049/JIMMUNOL.164.10.5023
Theofilos Poutahidis, Melanie M. Ihrig, Bruce H. Horwitz, Susan E. Erdman, Zhongming Ge, Arlin B. Rogers, Varada P. Rao, Michal Tomczak, Yan Feng, James G. Fox, CD4(+)CD25(+) Regulatory Lymphocytes Require Interleukin 10 to Interrupt Colon Carcinogenesis in Mice Cancer Research. ,vol. 63, pp. 6042- 6050 ,(2003)
Parris Kidd, Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Alternative medicine review : a journal of clinical therapeutic. ,vol. 8, pp. 223- 246 ,(2003)
L. G. Durrant, M. A. Chapman, D. J. Buckley, I. Spendlove, R. A. Robins, N. C. Armitage, Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunology, Immunotherapy. ,vol. 52, pp. 638- 642 ,(2003) , 10.1007/S00262-003-0402-Y
W J Adams, J A Lawson, D L Morris, Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut. ,vol. 35, pp. 1632- 1636 ,(1994) , 10.1136/GUT.35.11.1632
Takanori Kanai, Mamoru Watanabe, Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases. Expert Opinion on Biological Therapy. ,vol. 5, pp. 451- 462 ,(2005) , 10.1517/14712598.5.4.451
Elise Schmitt, Arnaud Parcellier, François Ghiringhelli, Noelia Casares, Sandeep Gurbuxani, Nathalie Droin, Ahmed Hamai, Marie Pequignot, Arlette Hammann, Monique Moutet, Annie Fromentin, Guido Kroemer, Eric Solary, Carmen Garrido, Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C. Cancer Research. ,vol. 64, pp. 2705- 2711 ,(2004) , 10.1158/0008-5472.CAN-03-2475
Akitake Suzuki, Akihiro Masuda, Hitoshi Nagata, Shingo Kameoka, Yayoi Kikawada, Mitsunori Yamakawa, Takeshi Kasajima, Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma The Journal of Pathology. ,vol. 196, pp. 37- 43 ,(2002) , 10.1002/PATH.1018